Tolerance
Description:
The new version of the Diagnostic and Statistical Manual (DSM V) is scheduled for publication in May 2013. The following website lists the new proposed criteria for a "Opioid Use Disorder" diagnosis.
Source:
American Psychiatric Association
Tags:
Description:
The Substance Abuse and Mental Health Services Administration (SAMHSA) provides this website so that physicians can improve the deliver and financing of prevention, treatment and recovery support services to patients.
Source:
Substance Abuse and Mental Health Services Administration (SAMHSA)
Tags:
- General information - opioid addiction
- General information - buprenorphine
- Screening and diagnosis
- Induction and dosing
- Rules, regulations and recordkeeping
- Physician and staff training
- Addiction
- Adolescents
- Dependence
- Pharmacotherapy
- Screening
- Side effects
- Tolerance
- Withdrawal
- Misc. informational materials
- Patient education materials
- Becoming waivered
- Experienced prescriber
- Just became waivered
- Need to refer
- Setting up a practice
Description:
Developed by a consensus panel, these guidelines provide treatment recommendations for patients with dual disorders.
Source:
U.S. Department of Health and Human Services, SAMHSA
Tags:
- Screening and diagnosis
- Special populations
- Managing challenging patients
- Addiction
- Assessment
- Behavioral therapy
- Comorbidities
- Complicated patients
- Dependence
- Drug interactions
- Expert panel
- Pharmacology
- Pharmacotherapy
- Pharmacy
- Polysubstance use
- Psychiatric
- Psychosocial
- Referral
- Relapse
- Risk factors
- Screening
- Side effects
- Special populations
- Symptoms
- Tolerance
- Withdrawal
- Treatment Algorithm
- Experienced prescriber
- Just became waivered
- Need to refer
Description:
This document discusses the logistics of successful buprenorphine induction, offering insight into clinical questions that should be addressed, the goal of induction, general principles, and recommendations based on low and high levels of evidence. Recommendations are included for both in-office and at-home inductions.
Source:
Physician Clinical Support System (PCSS) (2 votes)
Tags:
Description:
This CME course instructs physicians on some subtleties of buprenorphine treatment that can minimize the risk of the patient being harmed either by an adverse drug effect or by relapsing to opioid abuse.
Source:
Clinical Tools, Inc. (3 votes)
Tags:
